Chemical industry – Page 2
-
BusinessBayer ordered to pay more than $2 billion to US cancer victim
Jury decided glyphosate-based Roundup herbicide caused cancer, but company will appeal
-
OpinionHow a herbicide illustrates the many ways chemicals are put to the test
The glyphosate debate highlights the complexity of chemicals regulation
-
OpinionGetting into the weeds of the glyphosate debate
Assessments of the risk posed by the controversial herbicide depend on how the evidence is weighed
-
OpinionAre you fooling yourself?
Charles Piller’s Doctored and the reality of falsehoods in science
-
BusinessUS reviews chemical incident prevention planning rules
Risk Management Program has been extended and rolled back under successive governments
-
OpinionWeight loss drug supply races
With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of drugs
-
FeatureThe glyphosate debate
The EU has recently approved the use of glyphosate for another decade. Bárbara Pinho examines the controversial pesticide’s presence in British farming and considers the possibility of a ban in the UK
-
BusinessUS drops chloroprene emissions lawsuit against Denka
Government says lawsuit stretched legal definitions in pursuit of ‘environmental justice’
-
BusinessEnding of US weight-loss drug shortages prompts compounder complaints
Decision ends pharmacies’ permission to prepare versions of GLP-1 hormone mimics
-
OpinionWhy companies are rushing to flatter Trump
Pharma firms are among many pausing diversity programmes and promising domestic investment
-
BusinessNew Trump tariffs worry North American chemical industries
High duties on imports from Canada, Mexico and China raise problems for international supply chains
-
BusinessBiomanufacturing proliferates in chemicals
Fermentation can improve sustainability at competitive costs
-
BusinessChevron and BP cutting thousands of jobs
Oil industry is broadly looking to cut costs, increase oil and gas production and cut renewable investments
-
OpinionFluorine makes you an offer you can’t refuse
What might we do if we had a new, electron-donating equivalent element?
-
ResearchGenerative AI pipeline creates promising antimicrobial peptides
AI model extrapolates beyond training data to predict diverse antimicrobial structures
-
BusinessNew type of painkiller approved in US
Sodium channel blocker prevents nerves transmitting pain signals
-
FeaturePutting the F in pharma
Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame the ninth element
-
ResearchFar more drugs could be taken orally by formulating them with silica nanoparticles
Many more medicines could be made water soluble making taking them easier for patients
-
BusinessDow to cut 1500 jobs as global chemicals industry reshapes
US firm joins other industry heavyweights in shedding jobs to cut costs
-
ResearchMapping metabolite disturbances by drugs
High-throughput metabolomic profiling gives insight into unpredictable drug effects